Search results for " gamma delta T cells"

showing 8 items of 8 documents

Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes

2009

Colon cancer comprises a small population of cancer stem cells (CSC) that is responsible for tumor maintenance and resistant to cancer therapies, possibly allowing for tumor recapitulation once treatment stops. We previously demonstrated that such chemoresistance is mediated by autocrine production of IL-4 through the up-regulation of antiapoptotic proteins. Several innate and adaptive immune effector cells allow for the recognition and destruction of cancer precursors before they constitute the tumor mass. However, cellular immune-based therapies have not been experimented yet in the population of CSCs. Here, we show that the bisphosphonate zoledronate sensitizes colon CSCs to Vgamma9Vdelt…

Cytotoxicity ImmunologicDiphosphonatesTerpenesT-LymphocytesImidazolesReceptors Antigen T-Cell gamma-deltaZoledronic AcidColon cancer stem cells gamma delta T cellsNK Cell Lectin-Like Receptor Subfamily KColonic NeoplasmsNeoplastic Stem CellsCytokinesHumansChromaffin GranulesImmunotherapy
researchProduct

Human Vδ1+ T Cells in the Immune Response to Plasmodium falciparum Infection

2019

Naturally acquired protective immunity to Plasmodium falciparum malaria is mainly antibody-mediated. However, other cells of the innate and adaptive immune system also play important roles. These include so-called unconventional T cells, which express a γδ T-cell receptor (TCR) rather than the αβ TCR expressed by the majority of T cells-the conventional T cells. The γδ T-cell compartment can be divided into distinct subsets. One expresses a TCR involving Vγ9 and Vδ2, while another major subset uses instead a TCR composed of Vδ1 paired with one of several types of γ chains. The former of these subsets uses a largely semi-invariant TCR repertoire and responds in an innate-like fashion to pyro…

0301 basic medicinelcsh:Immunologic diseases. AllergyCell typeImmunologyPlasmodium falciparummalariaVdelta1 gamma delta T cells03 medical and health sciences0302 clinical medicineImmune systemAntigenparasitic diseasesImmunology and AllergyReceptorinnate immunityInnate immune systembiologyT-cell receptorgamma-delta (γ/δ) T lymphocytesPlasmodium falciparumAcquired immune systembiology.organism_classificationacquired immunity030104 developmental biologyImmunologylcsh:RC581-607030215 immunologyFrontiers in Immunology
researchProduct

Advances in immunotherapy of castration-resistant prostate cancer: Bisphosphonates, phosphoantigens and more.

2008

Settore MED/04 - Patologia Generaleprostate cancer bisphosphonates gamma delta T cells
researchProduct

Mechanisms underlying lineage commitment and plasticity of human γδ T cells.

2012

Phenotypic and functional heterogeneity are the hallmarks of effector and memory T cells. Upon antigen stimulation, γδ T cells differentiate into two major types of memory T cells: central memory cells, which patrol the blood and secondary lymphoid organs, and effector memory cells, which migrate to peripheral tissues. γδ T cells display in vitro a certain degree of plasticity in their function that is reminiscent of that which is observed in conventional CD4 T cells. Similar to CD4 T cells, in which a plethora of specialized subsets affect the host response, γδ T cells may readily and rapidly assume distinct Th1-, Th2-, Th17-, T(FH) and T regulatory-like effector functions, suggesting that…

ImmunologyReviewT-Lymphocytes RegulatoryInterleukin 21Cell MovementImmunology and AllergyCytotoxic T cellHumansIL-2 receptorAntigen-presenting cellhuman gamma delta T cells lineage subsets.Interleukin 3Settore MED/04 - Patologia GeneraleImmunity CellularCD40biologycytokines; effector and memory cells; γδ T cells; lineage-specifying factors; T-cell subsetsCell DifferentiationReceptors Antigen T-Cell gamma-deltaT-Lymphocytes Helper-InducerNatural killer T cellAcquired immune systemImmunity HumoralInfectious DiseasesImmunologybiology.proteinImmunologic Memory
researchProduct

Aminobisphosphonates as new weapons for gammadelta T Cell-based immunotherapy of cancer.

2008

BACKGROUND: Activated V gamma 9 V delta 2 T cells are able to kill most tumour cells because of recognition by T cell receptor and natural killer receptors. OBJECTIVE: We discuss the possibility that the intentional activation of gammadelta T cells in vivo by aminobisphosphonates may represent a promising target for the design of novel and highly innovative immunotherapy in cancer patients. METHODS: The antitumoral effects of gammadelta T cells both in vitro and in vivo have been demonstrated suggesting a new therapeutic approach for translation into the clinical setting. RESULTS/CONCLUSION: V gamma 9 V delta 2 T lymphocytes represent a particularly interesting target for immunotherapeutic …

Adjuvants ImmunologicDiphosphonatesCell Line TumorNeoplasmsT-LymphocytesProtein PrenylationAnimalsHumansReceptors Antigen T-Cell gamma-deltaImmunotherapyHuman gamma delta T cells tumors phosphoantigens bisphosphonates immunotherapyCurrent medicinal chemistry
researchProduct

Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system.

2013

Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system

Settore MED/04 - Patologia GeneraleButyrophilin 3A1ImmunologyAntigen presentationbiochemical phenomena metabolism and nutritionMHC restrictionBiologyANTIGENS CDInfectious DiseasesImmune systemphosphoantigenAntigenButyrophilinImmunologyImmunology and AllergyCytotoxic T cellhuman gamma delta T cells.CD8
researchProduct

Aminobisphosphonate-activated γδ T cells in immunotherapy of cancer: doubts no more

2008

BACKGROUND: Activated V gamma 9 V delta 2 T cells are able to kill most tumour cells because of recognition by T cell receptor and natural killer receptors. OBJECTIVE: We discuss the possibility that the intentional activation of gammadelta T cells in vivo by aminobisphosphonates may represent a promising target for the design of novel and highly innovative immunotherapy in cancer patients. METHODS: The antitumoral effects of gammadelta T cells both in vitro and in vivo have been demonstrated suggesting a new therapeutic approach for translation into the clinical setting. RESULTS/CONCLUSION: V gamma 9 V delta 2 T lymphocytes represent a particularly interesting target for immunotherapeutic …

Aminobisphosphonate Gamma delta T cells cancermedicine.medical_treatmentT cellClinical BiochemistryReceptors Antigen T-CellAntineoplastic AgentsModels BiologicalInterleukin 21Immune systemAntigenT-Lymphocyte SubsetsIn vivoNeoplasmsDrug DiscoveryAnimalsHumansCytotoxic T cellMedicinePharmacologyClinical Trials as TopicDiphosphonatesbusiness.industryT-cell receptorReceptors Antigen T-Cell gamma-deltaImmunotherapyKiller Cells Naturalmedicine.anatomical_structureImmune SystemImmunologyInterleukin-2ImmunotherapybusinessImmunologic MemoryExpert Opinion on Biological Therapy
researchProduct

Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity.

2007

Vgamma9Vdelta2 T cells have the ability to produce inflammatory cytokines involved in protective immunity against intracellular pathogens and tumours and to display strong cytolytic as well as bactericidal activities. This suggests a direct involvement of Vgamma9Vdelta2 T lymphocytes in immune control of cancer and infections. These observations have recently aided development of novel immunotherapeutic approaches aimed at Vgamma9Vdelta2 T cell activation. Nitrogen-containing bisphosphonates (N-BPs) play a crucial role in Vgamma9Vdelta2 T lymphocyte activation and in the acquisition of effector functions. The preliminary results of these innovative strategies are encouraging. Moreover, comp…

Protective immunitymedicine.medical_treatmentT cellT-Lymphocytesantitumour bisphophonate human gamma delta T cells immunomodulatory immunotherapyClinical BiochemistryAntineoplastic AgentsBiologyMonocytesProinflammatory cytokineT-Lymphocyte SubsetsNeoplasmsDrug DiscoverymedicineAnimalsHumansImmunologic FactorsPharmacologyDiphosphonatesMechanism (biology)Intracellular parasiteCancerImmunotherapyDendritic Cellsmedicine.diseaseCytolysismedicine.anatomical_structureImmunologyMolecular MedicineInterleukin-2Bone DiseasesExpert opinion on therapeutic targets
researchProduct